中文名 |
利马前列素 |
---|---|
英文名 |
(E)-7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S,5S)-3-hydroxy-5-methylnon-1-enyl]-5-oxocyclopentyl]hept-2-enoic acid |
中文别名 |
利马司特 | (2E,11Α,13E,15S,17S)-11,15-二羟基-17,20-二甲基-9-氧代前列-2,13-二烯-1-酸(2E,11Α,13E,15S,17S)-11,15-DIHYDROXY-17,20-DIMETHYL-9-OXOPROSTA-2,13-DIEN-1-OICACID |
英文别名 |
更多 |
描述 |
Limaprost(OP1206)是PGE1类似物,是血小板粘附抑制剂。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
溶解度 |
体外:
DMSO:≥40mg / mL(105.12 mM) * “≥”表示可溶,但饱和度未知。
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
O=C(O)/C=C/CCCC[C@@H]1[C@@H](/C=C/[C@@H](O)C[C@@H](C)CCCC)[C@H](O)CC1=O |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
甜橙黄酮 | Zomepirac钠盐 | 氟比洛芬 | 2-(9-氯-1H-菲酚[9,10-d]咪唑-2-基)-1,3-苯二甲腈 | 盐酸苄达明 | 碱式水杨酸铋 | HPGDS抑制剂1 | HPGDS-IN-1 | 泊米布洛芬 | 舒洛芬 | PGS-IN-1 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 550.6±50.0 °C at 760 mmHg |
熔点 | 97-100° |
分子式 | C22H36O5 |
分子量 | 380.518 |
闪点 | 300.9±26.6 °C |
精确质量 | 380.256287 |
PSA | 94.83000 |
LogP | 3.15 |
外观性状 | crystalline |
蒸汽压 | 0.0±3.4 mmHg at 25°C |
折射率 | 1.551 |
储存条件 | ?20°C |
水溶解性 | DMF: soluble |
分子结构 |
1、 摩尔折射率:108.52 2、 摩尔体积(cm3/mol):340.2 3、 等张比容(90.2K):908.2 4、 表面张力(dyne/cm):50.7 5、 极化率(10-24cm3):43.02 |
更多 |
1.性状:白色结晶。 2.熔点(℃):97~100。 |
利马前列素毒性英文版
|
符号 |
GHS06 |
---|---|
信号词 |
Danger |
危害声明 |
H300 |
警示性声明 |
P264-P301 + P310 |
个人防护装备 |
Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges |
危害码 (欧洲) |
T: Toxic; |
风险声明 (欧洲) |
25 |
安全声明 (欧洲) |
36/37/39-45 |
危险品运输编码 | UN 2811 6.1/PG 2 |
WGK德国 | 3 |
RTECS号 | UK8362500 |
88mg化合物(I)和357mg4-二甲氨基吡啶溶于二氯甲烷,在冰浴冷却下加入116脚甲磺酰氯。加毕,在30℃反应2.5h,得到94%的化合物(Ⅱ)。80mg化合物(Ⅱ)和800mg锌在含乙酸的异丙醇中,在50℃反应2h,得到66%的化合物(Ⅲ)。再酸性(如三氟乙酸或甲磺酸)水解为化合物(Ⅳ),最后用猪肝酯酶水解,得到利马前列素。
OP-1206, a prostaglandin E1 derivative, attenuates the thermal hyperesthesia induced by constriction injury to the sciatic nerve in the rat. Anesth. Analg. 80(3) , 515-20, (1995)
Nerve ischemia induces wallerian degeneration and peripheral neuropathy, the nerve constriction injury induces thermal hyperesthesia. Nerve ischemia is one possible mechanism in the development of the…
|
|
Inhibition of platelet aggregation by the cAMP-phosphodiesterase inhibitor, cilostamide, may not be associated with activation of cAMP-dependent protein kinase. Cell. Signal. 4(4) , 453-63, (1992)
We examined the involvement of cAMP-dependent protein kinase (A kinase)2 in the inhibition by cilostamide, a specific inhibitor of the low Km cAMP-phosphodiesterase (PDE), on 9,11-epithio-11,12-methan…
|
|
Correlation between methotrexate-induced intestinal damage and decrease in polyamine content. Life Sci. 72(6) , 669-76, (2002)
A synthetic analog of prostaglandin E(1), OP-1206 [17S, 20-dimethyl-trans-Delta(2)-prostaglandin E(1)] protects the small intestine from the methotrexate (MTX)-induced damage. The purpose of this stud…
|
|
17S,20-Dimethyl-trans-delta2-PGE1 |
(E)-7-((1R,2R,3R)-3-Hydroxy-2-((E)-(3S,5S)-3-hydroxy-5-methyl-1-nonenyl)-5-oxocyclopentyl)-2-heptenoic acid |
(2E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methylnon-1-en-1-yl]-5-oxocyclopentyl}hept-2-enoic acid (non-preferred name) |
Limaprost |
(2E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(1E,3S,5S)-3-hydroxy-5-methyl-1-nonen-1-yl]-5-oxocyclopentyl}-2-heptenoic acid |
9-Oxo-11a,15a-dihydroxy-17S,20-dimethylprosta-trans-2,trans-13-dienoic Acid |
17S,20-Dimethyl-trans-2,3-didehydro-PGE1 |
(2E,11a,13E,15S,17S)-11,15-Dihydroxy-17,20-dimethyl-9-oxoprosta-2,13-dien-1-oic Acid |
17S-Methyl-w-homo-trans-D2-PGE1 |
ONO 1206 |
OP 1206 |